- 3rd November, 2009
- Geneva, Switzerland
The Pharmaceutical Care Network Europe strongly believes that in order to develop high quality research, you need to continually update yourself, and exchange expertise and experience with colleagues in the same research field. Workshops and working conferences are organised in that context.
On the 2nd and 3rd of November 2009, two symposia were organised by the Pharmaceutical Care Network Europe at the University of Geneva’s science building. Researchers from all over Europe used this opportunity to network, and to contribute to the concepts behind such topics as medication errors, drug-related problems and medication review.
The PCNE classification for Drug-related problems is widely used. However, it needed to be updated according to the most recent conceptual developmens For this sympsoium, PCNE developped a three-step model for medication review, that is based on the available information in different the practice setting.
PCNE would like to thank the Departments of Pharmacy of the Universities of Geneva & Lausanne for their wonderful organisational support
Studying services and Pharmaceutical care delivery, a novice workshop
Workshop facilitators: Dr. Cecilia Bernsten (Sweden), Ms. Suzete Costa (Portugal)
Description: In this workshop the participants looked at the evaluation of new types of services, such as point of care testing, transfer of care between hospital and community pharmacy, and care to vulnerable patient groups. A study protocol was developed.
Workshop Reports
Developing a framework for conducting ethical pharmaceutical care research
Cancelled
Competency versus performance in pharmaceutical care education
Workshop facilitators: Dr. Martin Helman (Ireland), Dr. Pilar Modamio (Spain) and Prof. Dr. David Graham (UK)
Description: To deliver pharmaceutical care, researchers and practitioners usually decide that education is required. However, much of this focuses on knowledge of the conditions and drug therapy being addressed and on the processes of the research or health service programme. Although some of the barriers to the implementation of pharmaceutical care research and practice are being researched, little attention has been paid to education. Research and Practice competencies have been described but experience with Continuing Professional Development suggests that competence under ‘test’ conditions is no guarantee of performance in practice. This workshop has explored these issues from the undergraduate to the lifelong learning stages and from the research and practice perspectives.
Innovation in quantitative pharmaceutical care research, an advanced workshop about longitudinal data
Workshop facilitators: Dr. Margaret Watson (United Kingdom) , Dr. Afonso Cavaco (Portugal)
Description: The purpose of this workshop was to provide an overview and discussion of the use of observation as a research method in general and in pharmaceutical care research in particular. The aim of the workshop was for participants to gain an understanding of the use of observation as a research method, and its application to pharmaceutical care research. The workshop also provided an environment where participants could discuss their experience of this method and qualitative research in general, the strengths and limitations associated with its use, and developped protocols and frameworks for the use of this method for forthcoming studies.
Integrating & using multidisciplinary patient records
Workshop facilitators: Dr. Tracey Farragher (United Kingdom), and Dr. R. Holland (United Kingdom)
Description:Longitudinal studies are those in which data are measured repeatedly over time. These studies are playing an increasing role in the health and medical sciences as well as in pharmaceutical studies. This workshop introduced the design, analysis and interpretation of two of the most common types of longitudinal studies using real-life published examples and the statistical package SPSS. The workshop explored modelling the change over time, not only of the individuals but also the differences in change across people. The workshop also explored how to summarise this type of data as well as the modelling of the different aspects of change using multi-level models – fixed and random effects. The workshop also looked at survival studies, which are concerned with studying the time between entry to a study and a subsequent event (e.g. death, treatment discontinuation or clinical outcome/success). A number of methods such as life table, Kaplan-Meier survival curves as well as comparison and modellling of survival (log rank test and Cox regression) were studied.
Introductions PCNE Drug Related Problems
“Developing a DRP classification – a never ending story?”
Foppe van Mil, van Mil Consultancy, the Netherlands
Classification of drug-related problems with new prescriptions using a modified PCNE classification system.
Patrick Eichenberger, University Basle, Switzerland
Community Pharmacy DRP Documentation – the Swedish Way
Tommy Westerlund, Apoteket, Helsingborg, Sweden
Drug related problems among elderly who received comprehensive medication review
Saija Leikola, University of Helsinki, Finland
Patterns of drug-related problems – results of three German surveys
Nina Griese, ABDA Berlin, Germany
Workshop reports PCNE Drug Related Problems
Workshop 1
Defining DRPs and medication errors and their relationships.
Chair: Nina Griese, Germany
The definitions of DRPs and Medication errors are different but seem alike. But the words ‘Problem’ and ‘Error’ indicate clear differences. There are medication errors that have no or not necessarily impact on outcomes, not even potentially (timing errors in administration). There are also DRPs that are not medication errors (the occurrence of ADRs). What is the overlap? Are medication errors possible causes for drug-related problems? What are valid definitions?
Workshop 2
The PCNE classification 5.1 vs 6.
Chair: Foppe van Mil, the Netherlands
Are all problems in the V5.1 indeed DRPs or causes? Did we cover all problems, or are there unmentioned DRPs. Is the proposed V6 the solution or are more adaptations necessary.
Workshop 3
Usability and validity of a classification.
Chair: Tommy Westerlund, Sweden
Many assessors (researchers and/or pharmacists) do not find a (any) classification easy to use. Can this be mended? Is some sort of training desirable/necessary, and under what circumstances? Can a DRP classification be applicable for both community and hospital? Can it be used for documenting problems in retrospective medication review? What needs to be adapted for optimal usability?
Introductions PCNE Medication review
“Introduction to medication review, why and how”
Foppe van Mil, van Mil Consultancy, the Netherlands
Polymedication check – a new reimbursed service for Swiss community pharmacists
Kurt Hersberger, University Basle, Switzerland
Comprehensive medication review involving collaboration between pharmaciist and physicians practice in Finland
Saija Leikola, University of Helsinki, Finland
Medication Review in Belgium
Veerle Foulon, University of Leuven, Belgium
Explicit standards to evaluate the quality and safety of medication use in primary care & A generic algorithm to operationalise ‘adherence to standards’ as an intermediate outcome measure
Tobias Dreischulte, University of Dundee & University of Strathclyde, Scotland